Manuel A. Pascual

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


411 publications

... | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | ...
 
Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovir.
Perrottet N., Csajka C., Pascual M., Manuel O., Lamoth F., Meylan P., Aubert J.D., Venetz J.P., Soccal P., Decosterd L.A. et al., 2009. Antimicrobial agents and chemotherapy, 53 (7) pp. 3017-23.
 
Role of the naive and memory CD4+T-cell repertoire in transplantation
Golshayan D., Wyss J.C., Hernandez-Fuentes M., Pascual M., Lechler R., 2009. pp. 3S dans Annual meeting of the Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
Short-course thymoglobulin induction and steroid-free immunosuppressive regimen in renal transplantation
Hadaya K., Venetz J.P., Ponte B., Vallotton L., Buhler L., Pascual M., Martin P.Y., 2009. pp. 6S dans Annual meeting of the Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
Suivi du patient après transplantation cardiaque: monitoring et adaptation de l'immunosuppression [Monitoring and adjustment of immunosuppression after heart transplantation].
Yerly P., Mach F., Kalangos A., Rotman S., von Segesser L., Vogt P., Hullin R., Pascual M., 2009. Revue Médicale Suisse, 5 (205) pp. 1214-1220.
 
The role of significant others in the course of transplantation through the patients points of view : a longitudinal study.
Bridy C., Bosisio F., Pralong L., Pascual M., Piot-Ziegler C., 2009. dans 14th ESOT Congress, European Society for Organ Transplantation. Peer-reviewed.
 
Time-Course In Vivo Trafficking Pattern and Effector Function of Donor-Specific Regulatory T Cells in Response to an Allograft.
Golshayan Dela, Wyss Jean-Christophe, Abulker Caroline Wyss, Schaefer Stephan, Lechler Robert I., Lehr Hans-Anton, Pascual Manuel, 2009. p. 541 dans 9th Joint Meeting of the American Society of Transplant Surgeon and of the American Society of Transplantation, American Journal of Transplantation. Peer-reviewed.
 
Transplantation tolerance induced by regulatory T cells: in vivo mechanisms and sites of action.
Golshayan D., Wyss J.C., Abulker C.W., Schaefer S.C., Lechler R.I., Lehr H.A., Pascual M., 2009. International Immunopharmacology, 9 (6) pp. 683-688. Peer-reviewed.
 
Usefulness of a routine monitoring of cytomegalovirus viremia after discontinuation of antiviral prophylaxis in kidney transplantation : P117
Boillat N., Pascual M., Venetz J.P., Meylan P.R, Manuel O., 2009. pp. 31S dans Joint Annual Congress of the Swiss Society for Allergology and Immunology and the Swiss Society for Infectious Diseases, Swiss Medical Weekly. Peer-reviewed.
 
Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.
Perrottet N., Decosterd L.A., Meylan P., Pascual M., Biollaz J., Buclin T., 2009. Clinical Pharmacokinetics, 48 (6) pp. 399-418. Peer-reviewed.
 
Case Report: Human herpesvirus 6 reactivation associated with colitis in a lung transplant recipient
Lamoth F., Jayet P.Y., Aubert J.D., Rotman S., Mottet C., Sahli R., Lautenschlager I., Pascual M., Meylan P., 2008/10. Journal of Medical Virology, 80 (10) pp. 1804-1807.
 
Absence of BK viremia clearance after low-dose cidofovir therapy in kidney transplant recipients with BK virus associated nephropathy
Lamoth Frederic, Pascual Manuel, Nseir Ghaleb, Venetz Jean-Pierre, Meytan Pascal R., 2008. pp. S12-S13 dans Abstracts of the 15th International Symposium on Infections in the Immunocompromised Host, International Journal of Infectious Diseases. Peer-reviewed.
 
Allograft Rejection in Kidney Transplantation
Pascual M., 2008. International Transplantation Updates, 10 141, Permanyer.
 
Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
Bianchi E., Pascual M., Nicod M., Delaloye A.B., Duchosal M.A., 2008. Transplantation, 85 (5) pp. 707-712. Peer-reviewed.
 
Cost effectiveness of a new combined immunosuppressive and antiviral regimen on the one-year follow-up of kidney transplant patients.
Manuel Oriol, Kast-Bruechner Mira, Venetz Jean-Pierre, Meylan Pascal R., Pascual Manuel, Wasserfallen Jean-Blaise, 2008. pp. 395-395 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation.
Wasserfallen J.B., Kast-Brückner M., Manuel O., Venetz J.P., Meylan P.R., Pascual M., 2008. International Journal of Technology Assessment In Health Care, 24 (3) pp. 312-317.
 
CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.
Crettol S., Venetz J.P., Fontana M., Aubert J.D., Pascual M., Eap C.B., 2008. Therapeutic Drug Monitoring, 30 (6) pp. 689-699. Peer-reviewed.
 
Cytomegalovirus infection and new-onset post-transplant diabetes mellitus.
Leung Ki E.L., Venetz J.P., Meylan P., Lamoth F., Ruiz J., Pascual M., 2008. Clinical Transplantation, 22 (2) pp. 245-249.
 
Disposition of oral valganciclovir during continuous renal replacement therapy in two lung transplant recipients
Perrottet Nancy, Robatel Corinne, Meylan Pascal, Pascual Manuel, Venetz Jean-Pierre, Aubert John-David, Berger Mette M., Decosterd Laurent A., Biollaz Jerome, Buclin Thierry, 2008. p. 566 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients.
Perrottet N., Robatel C., Meylan P., Pascual M., Venetz J.P., Aubert J.D., Berger M.M., Decosterd L.A., Buclin T., 2008. Journal of Antimicrobial Chemotherapy, 61 (6) pp. 1332-1335.
 
Existential questionings during the pretransplantation period: A qualitative phenomenological study
Piot-Ziegler C., Bonner Ruffiner N., Fasseur F., Santiago-Delefosse M., Pascual M., 2008. p. 30 dans Joint BPS (British Psychological Society's) Division of Health Psychology/European Health Psychology Society Annual Conference 2008, Psychology and Health.
 
Existential values transformation in all organ transplantation: A qualitative prospective study.
Piot-Ziegler Chantal, Ruffiner-Boner Nadja, Cuttelod Therese, Fonjallaz Floriane, Pilon Nathalie, Pascual Manuel, 2008. p. 400 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Experimental Gene Therapy of Heart Transplantation
Vassalli G., Seydoux C., Vogt P., Pascual M., Von Segesser L.K., 2008. pp. - dans Ashan N. (eds.) Chronic allograft failure: natural history, pathophysiology, diagnosis and managements chap. 11, Landes Bioscience.
 
From dialysis to transplantation, illness experience and patients' concerns about future: A longitudinal qualitative study
Piot-Ziegler C., Szymanski J., Ruffiner-Boner N., Fasseur F., Santiago M., Pascual M., 2008. p. 210 dans Joint BPS (British Psychological Society's) Division of Health Psychology/European Health Psychology Society Annual Conference 2008, Psychology and Health.
 
HCV infection after liver transplantation is associated with lower levels of alloreactive CD4+CD25+CD45RO+IL-7R+high+ T cells
Ciuffreda Donatella, Codarri Laura, Buhler Leo, Giostra Emiliano, Mentha Gilles, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 389 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Hemophagocytic syndrome after highly active antiretroviral therapy initiation: a life-threatening event related to immune restoration inflammatory syndrome?
Cuttelod M., Pascual A., Baur Chaubert A.S., Cometta A., Osih R., Duchosal M.A., Cavassini M., 2008. AIDS, 22 (4) pp. 549-551.
 
Hepatitis C virus infection in haemodialysis and kidney transplant patients.
Baid-Agrawal S., Pascual M., Moradpour D., Frei U., Tolkoff-Rubin N., 2008. Reviews in Medical Virology, 18 (2) pp. 97-115. Peer-reviewed.
 
Immunosuppression and clinical tolerance of allografts
Golshayan D., Pascual M., 2008. pp. 125-141 dans Arias Rodriguez M. (eds.) Tolerancia y trasplante de organos, Drug Farma.
Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences
Legendre C., Pascual M., 2008. Clinical Infectious Diseases, 46 (5) pp. 732-740. Peer-reviewed.
 
In vivo mechanisms leading to transplantation tolerance induced by regulatory T cells
Golshayan D., Wyss J.C., Wyss C., Schaefer S., Lechler R., Lehr H.A., Pascual M., 2008. pp. 6S dans 40th Annual Meeting Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients
Crettol Séverine, Venetz Jean-Pierre, Fontana Massimiliano, Aubert John-David, Ansermot Nicolas, Fathi Marc, Pascual Manuel, Eap Chin-Bin, 2008. Pharmacogenetics and Genomics, 18 (4) pp. 307-315. Peer-reviewed.
 
Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature.
Lamoth Frederic, Pascual Manuel, Erard Veronique, Venetz Jean-Pierre, Nseir Ghaleb, Meylan Pascal, 2008. Antiviral Therapy, 13 (8) pp. 1001-1009. Peer-reviewed.
 
Low-dose valganciclovir is efficacious and safe for prophylaxis of cytomegalovirus infection in kidney transplantation
Perrottet Nancy, Manuel Oriol, Venetz Jean-Pierre, Lamoth Frederic, Decosterd Laurent A., Buclin Thierry, Biollaz Jerome, Meylan Pascal, Pascual Manuel, 2008. pp. 565-566 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantation.
Golshayan D., Pascual M., 2008. Transplant Immunology, 20 (1-2) pp. 21-28.
 
Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation.
Laffitte E., Venetz J.P., Aubert J.D., Duchosal M.A., Panizzon R.G., Pascual M., 2008. Dermatology, 217 (1) pp. 87-88.
 
No detectable indirect effects of late-onset Cytomegalovirus disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
Lamoth Frederic, Manuel Criol, Meylan Pascal R., Venetz Jean-Pierre, Faouzi Mohammed, Pascual Manuel, 2008. pp. S13 dans Abstracts of the 15th International Symposium on Infections in the Immunocompromised Host, International Journal of Infectious Diseases. Peer-reviewed.
 
No evidence of indirect effects of late-onset cytomegalovirus (CMV) disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
Manuel Oriol, Lamoth Frederic, Meylan Pascal R., Fellay Jacques, Venetz Jean-Pierre, Pascual Manuel, 2008. p. 527 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
Optimal prevention of late-onset cytomegalovirus (CMV) disease and other sequelae of CMV infection in organ transplant recipients - Reply
Legendre Christophe, Pascual Manuel, 2008. Clinical Infectious Diseases, 47 (2) pp. 297-298.
 
Patients' spontaneous discourse on the importance of significant others in the course of transplantation: A qualitative study
Bridy C., Ruffiner-Boner N., Fasseur F., Santiago M., Pascual M., Piot-Ziegler C., 2008. p. 73 dans Joint BPS (British Psychological Society's) Division of Health Psychology/European Health Psychology Society Annual Conference 2008, Psychology and Health.
 
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
Ciuffreda D., Comte D., Cavassini M., Giostra E., Bühler L., Perruchoud M., Heim M.H., Battegay M., Genné D., Mulhaupt B. et al., 2008. European Journal of Immunology, 38 (10) pp. 2665-2677.
 
Prevalence and significance of anti-HILA antibodies after liver transplantation : P236
Fontana M., Moradpour D., Aubert V., Estoppey M., Rotman S., Pascual M., 2008. pp. 54S-55S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Prevalence and significance of anti-HLA antibodies after liver transplantation
Fontana Massimiliano, Moradpour Darius, Aubert Vincent, Estoppey Michele, Rotman Samuel, Pascual Manuel, 2008. pp. S226-S227 dans 14th Annual International Congress of the International Liver Transplantation, Liver Transplantation. Peer-reviewed.
 
Prospective monitoring of a CD4(+) CD25(high) CD45RO(+) CD127(high) T cell population after first kidney transplantation following thymoglobulin or basiliximab induction
Vallotton Laure, Hadaya Karine, Ciuffreda Donatella, Buhler Leo, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 473 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Prospective monitoring of a CD4+ CD25high CD45RO+ CD127high T-cell population after first kidney transplantation following thymoglobulin or basiliximab induction
Vallotton L., Hadaya K., Buhler L., Ciuffreda D., Venetz J.P., Pantaleo G., Pascual M., 2008. pp. 57S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
Prévalence de la dénutrition chez 143 adultes en bilan prétransplantation hépatique. Experience lausannoise de 1997 a 2005 [Prevalence of undernutrition in 143 patients before liver transplantation. The Lausanne experience between 1997 and 2005]
Guex E., Cheseaux M., Coti Bertrand P., Piquet M.A., Bouvry S., Pilon N., Halkic N., Pascual M., Roulet M., 2008. Revue Médicale Suisse, 4 (152) pp. 927-930. Peer-reviewed.
 
Psychological stakes before and after transplantation : a prospective qualitative study
Piot-Ziegler C., Ruffiner-Boner N., Cuttelod T., Fonjallaz F., Szymanski J., Fasseur F., Pilon N., Weigand I., Aubert JD., Pascual M., 2008., ATC Toronto Canada dans American Transplant Conference Book. Peer-reviewed.
 
Quality of life transformation before and after kidney transplantation : a prospective qualitative study
Piot-Ziegler C., Szymanski J., Ruffiner-Boner N., Weigand I., Santiago M., Venetz J-P., Pascual M., 2008., ATS dans American Transplant Conference Book. Peer-reviewed.
 
Quality of life transformations before and after kidney transplantation: A prospective qualitative study.
Piot-Ziegler Chantal, Szymanski Jennifer, Ruffiner-Boner Nadja, Weigand Isabelle, Santiago Marie, Venetz Jean-Pierre, Pascual Manuel, 2008. pp. 400-401 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Rôle du pathologiste en transplantation [The pivotal role of the pathologist in transplantation]
Rotman S., Fontana M., Seydoux C., Venetz J.P., Aubert J.D., Pascual M., 2008. Revue Médicale Suisse, 4 (145) pp. 480-483.
 
Spontaneous discourse on employment status and professional identity of patients waiting for solid organ transplantation
Fonjallaz F., Fasseur F., Ruffiner-Boner N., Cuttelod T., Szymanski J., Santiago M., Pilon N., Venetz J.P., Pascual M., Piot-Ziegler C., 2008. pp. 488-495 dans Weimar W., Bos M.A., Busschbach J.J. (eds.) Organ Transplantation: Ethical, Legal and Psychosocial Aspects. Towards a Common European Policy, Pabst Science Publishers.
 
Switch to Sirolimus-based immunosuppresion in stable renal transplant recipients
Nseir G., Venetz J.P, Hadaya K., Buhler L., Martin P.Y., Pascual M., 2008. pp. 18S dans 40th Annual Meeting Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
The presence of a CD4(+) CD25(high) CD45RO(+) CD127(high) T cell population correlates with the clinical status of kidney transplant recipients
Vallotton Laure, Codarri Laura, Ciuffreda Donatella, Hadaya Karine, Buhler Leo, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 473 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
The presence of a CD4+ CD25high CD45RO+ CD127high T-cell population correlates with the clinical status of kidney transplant recipients
Vallotton L., Codarri L., Ciuffreda D., Hadaya K., Buhler L., Venetz J.P., Pantaleo G., Pascual M., 2008. pp. 57S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.
Golshayan D., Pascual M., 2008. Drugs, 68 (15) pp. 2113-2130.
 
Transplantation hépatique : introduction en Suisse d'un nouveau système d'allocation des organes [Liver transplantation: new organ allocation system in Switzerland]
Fontana M., Giostra E., Pilon N., Michetti P., Mentha G., Pascual M., Moradpour D., 2008. Revue Médicale Suisse, 4 (141) pp. 221-223.
 
Transplantation rénale: y a-t-il un âge limite ?
Kissling S., Pascual M., Venetz JP., 2008. Geriatrie Pratique, 1 pp. 15-20.
 
Treatment of antibody-mediated rejection in kidney transplantation
Venetz J.P., Pascual M., 2008. EJHP Practice, 14 (5) pp. 21-24.
 
What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?
Lamoth F., Manuel O., Venetz J.P., Faouzi M., Meylan P., Pascual M., 2008. Transplantation, 86 (9) pp. 1323-1324.
 
Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.
Manuel O., Venetz J.P., Fellay J., Wasserfallen J.B., Sturzenegger N., Fontana M., Matter M., Meylan P.R., Pascual M., 2007/12/01. Swiss medical weekly, 137 (47-48) pp. 669-676. Peer-reviewed.
 
Meningococcal disease in a kidney transplant recipient with mannose-binding lectin deficiency.
Manuel O., Tarr P.E., Venetz J.P., Trendelenburg M., Meylan P.R., Pascual M., 2007/09. Transplant Infectious Disease, 9 (3) pp. 214-218. Peer-reviewed.
 
Determination of aciclovir and ganciclovir in human plasma by liquid chromatography-spectrofluorimetric detection and stability studies in blood samples
Perrottet N., Beguin A., Meylan P., Pascual M., Manuel O., Buclin T., Biollaz J., Decosterd L. A., 2007/06. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 852 (1-2) pp. 420-9.
 
New treatments for acute humoral rejection of kidney allografts.
Venetz J.P., Pascual M., 2007/05. Expert Opinion on Investigational Drugs, 16 (5) pp. 625-633.
 
Cytomegalovirus in transplantation - challenging the status quo.
Fishman J.A., Emery V., Freeman R., Pascual M., Rostaing L., Schlitt H.J., Sgarabotto D., Torre-Cisneros J., Uknis M.E., 2007/04. Clinical Transplantation, 21 (2) pp. 149-158.
 
Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation.
Manuel O., Pascual M., Trendelenburg M., Meylan P.R., 2007/02. Transplantation, 83 (3) pp. 359-362. Peer-reviewed.
 
Association between mannose-binding lectin (MBL) deficiency and cytomegalovirus (CMV) infection after kidney transplantation
Trendelenburg Marten, Manuel Oriol, Pascual Manuel, Schifferli Jürg A., Meylan Pascal, 2007. p. 251 dans 21st International Complement Workshop, Molecular Immunology. Peer-reviewed.
 
Association between mannose-binding lectin deficiency and cytornegalovirus infection course after organ transplantation.
Manuel Oriol, Pascual Manuel, Trendelenburg Marten, Muheim Carmen, Meylan Pascal R., 2007. p. 501 dans Annual American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
Fontana M., Ciuffreda D., Moradpour D., Pascual M., 2007. Transplantation, 83 (4) pp. 525-526.
 
Cost-effectiveness of a new combined immunosupressive regimen in kidney transplantation
Wasserfallen Jean-Blaise, Kast-Brückner Mira, Manuel Oriol, Venetz Jean-Pierre, Meylan Pascal, Pascual Manuel, 2007. pp. 40S dans Annual Conference of the Swiss Respiratory Society, Swiss Medical Weekly. Peer-reviewed.
 
Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation.
Ciuffreda D., Pantaleo G., Pascual M., 2007. Transplant International, 20 (8) pp. 649-658. Peer-reviewed.
Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.
Manuel O., Venetz J.P., Fellay J., Wasserfallen J.B., Sturzenegger N., Fontana M., Matter M., Meylan P.R., Pascual M., 2007. Swiss Medical Weekly, 137 (47-48) pp. 669-676. Peer-reviewed.
Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients.
Codarri L., Vallotton L., Ciuffreda D., Venetz J.P., Garcia M., Hadaya K., Buhler L., Rotman S., Pascual M., Pantaleo G., 2007. Journal of Experimental Medicine, 204 (7) pp. 1533-1541. Peer-reviewed.
 
From current immunosuppressive strategies to clinical tolerance of allografts.
Golshayan D., Buhler L., Lechler R.I., Pascual M., 2007. Transplant International, 20 (1) pp. 12-24. Peer-reviewed.
Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats.
Simeoni E., Dudler J., Fleury S., Li J., Pagnotta M., Pascual M., von Segesser L.K., Vassalli G., 2007. European Journal of Cardio-thoracic Surgery, 31 (2) pp. 222-228. Peer-reviewed.
 
Gene transfer of interleukin-18-binding protein attenuates cardiac allograft rejection.
Dudler J., Simeoni E., Fleury S., Li J., Pagnotta M., Pascual M., von Segesser L.K., Vassalli G., 2007. Transplant International, 20 (5) pp. 460-466. Peer-reviewed.
 
Homeostasis and in vivo effector function of antigen-specific CD4+CD25+ regulatory T cells in experimental transplantation.
Golshayan Dela, Schaefer Stephan, Jiang Shuiping, Pascual Manuel, Lehr Hans-Anton, Lechler Robert I., 2007. p. 172 dans Annual American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Identification of an expanded population of activated CD4(+) CD25(+) T cells expressing CD45RO and IL-7R in kidney transplant recipients
Vallotton Laure, Codarri Laura, Ciuffreda Donatella, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2007. p. 153 dans 13th Congress of the European Society for Organ Transplantation and the 15th Congress of the European Transplant Coordinators Organization, Transplant International. Peer-reviewed.
 
Identification of an expanded population of activated CD4(+)CD25(+)CD45RO(+)IL-7R(+) T cells in liver transplant recipients: downmodulation by HCV
Ciuffreda D., Codarri L., Pascual M., Pantaleo G., 2007. pp. 18S dans Annual Conference Swiss Society for Allergology and Immunology, Spring Meeting Swiss Society of Dermatology and Venerology, Swiss Medical Weekly. Peer-reviewed.
 
Oral valganciclovir for cytomegalovirus colitis after liver transplantation.
Manuel O., Meylan P.R., Rotman S., Fontana M., Moradpour D., Pascual M., 2007. Transplantation, 83 (2) pp. 239-240. Peer-reviewed.
 
Pharmacokinetic and pharmacodynamic assessement of valganciclovir in the prophylaxis and treatment of CMV disease in solid organ transplant patients
Manuel O., Perrottet N., Lamoth F., Venetz J.P., Decosterd L.A., Buclin T., Pascual M., Meylan P., 2007. pp. 9S dans Annual Conference Swiss Society for Paediatrics, Swiss Medical Weekly. Peer-reviewed.
 
Psychological transformations in kidney transplantation: A prospective qualitative study
Piot-Ziegler Chantal, Szymanski Jennifer, Ruffiner-Boner Nadja, Fasseur Fabienne, Maillefer Julia, Weigand Isabelle, Venetz Jean-Pierre, Santiago Marie, Pascual Manuel, 2007. p. 181 dans 13th Congress of the European Society for Organ Transplantation and the 15th Congress of the European Transplant Coordinators Organization, Transplant International. Peer-reviewed.
 
Drug-minimization or tolerance-promoting strategies in human kidney transplantation: is Campath-1H the way to follow?
Golshayan D., Pascual M., 2006/11. Transplant International, 19 (11) pp. 881-4.
 
Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation
Wong W., Agrawal N., Pascual M., Anderson D. C., Hirsch H. H., Fujimoto K., Cardarelli F., Winkelmayer W. C., Cosimi A. B., Tolkoff-Rubin N., 2006/08. Transplant International, 19 (8) pp. 629-35. Peer-reviewed.
Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation.
Ferrari-Lacraz Sylvie, Aubert Vincent, Buhler Leo, Pascual Manuel, Andresen Irmgard, Binet Isabelle, Martin Pierre-Yves, Villard Jean, 2006. Swiss Medical Weekly, 136 (43-44) pp. 696-702.
 
De novo concurrent papillary renal cell carcinoma and angiomyolipoma in a kidney allograft: evidence of donor origin.
Rotman S., Déruaz C., Venetz J.P., Chaubert P., Benhattar J., Meuwly J.Y., Jichlinski P., Guillou L., Moll S., Pascual M. et al., 2006. Human Pathology, 37 (4) pp. 481-487.
 
Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival.
Dudler J., Li J., Pagnotta M., Pascual M., von Segesser L.K., Vassalli G., 2006. Transplantation, 82 (12) pp. 1733-7. Peer-reviewed.
 
Maladies inflammatoires cryptogéniques de l'intestin de novo après transplantation hépatique: rapport de quatre nouveaux cas et revue de la littérature [De novo inflammatory bowel diseases after liver transplantation: description of four new cases and a review of the literature]
Vu F., Maillard M., Pascual M., Michetti P., Felley C., 2006. Gastroentérologie clinique et biologique, 30 (8-9) pp. 1096-101. Peer-reviewed.
 
Meningococcal disease in a kidney transplant recipient with mannose-binding lectin (MBL) deficiency
Manuel O., Tarr R., Venetz J.P., Trandelenburg M., Meylan P., Pascual M., 2006. pp. S16 dans 12th International Society for infectious Diseases, International Journal of Infectious Diseases. Peer-reviewed.
 
Oral valganciclovir prophylaxis in kidney transplant recipients
Manuel O., Fellay J., Venetz J.P., Sturzenegger N., Meylan R., Pascual M., 2006. pp. S16 dans 12th International Society for infectious Diseases, International Journal of Infectious Diseases. Peer-reviewed.
 
Pharmacokinetic and pharmacodynamic evaluation of valganciclovir in solid organ transplant patients
Manuel O., Perrottet N., Venetz J.P., Decosterd L.A., Buclin T., Pascual M., Meylan P., 2006. pp. S19 dans 12th International Society for infectious Diseases, International Journal of Infectious Diseases. Peer-reviewed.
Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.
Meylan P.R., Pascual M., 2006. Clinical Infectious Diseases, 43 (7) pp. 881-883. Peer-reviewed.
 
Rechazo agudo humoral posttrasplante renal: manifestaciones clinicas e histologicas y bases para la terapeutica
Crespo M, Moll S, Pascual M, 2006. pp. pp. 31-54 dans Drug Farma, Edificio Vertice Antonio Lopez (eds.) Biblioteca de Trasplantes Siglo XXI. Rechazo humoral, Rodriguez, Manuel Arias.
 
Sensitization after kidney transplantation.
Akalin E., Pascual M., 2006. Clinical Journal of the American Society of Nephrology, 1 (3) pp. 433-440.
 
Humoral rejection of organ allografts.
Moll S., Pascual M., 2005/11. American Journal of Transplantation, 5 (11) pp. 2611-2618.
 
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors?
Wong W., Venetz J.P., Tolkoff-Rubin N., Pascual M., 2005/08. Transplantation, 80 (3) pp. 289-296.
 
Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
Cardarelli F., Pascual M., Tolkoff-Rubin N., Delmonico F.L., Wong W., Schoenfeld D.A., Zhang H., Cosimi A.B., Saidman S.L., 2005/05. Transplant International, 18 (5) pp. 532-540.
 
Chirurgie viscérate chez le patient greffé ou en attente d'une transplantation [Visceral surgery in organ transplant recipients or in patients awaiting transplantation].
Matter M., Saucy F., Venetz J.P., Pascual M., 2005. Revue Médicale Suisse, 1 (24) pp. 1608-1615.
 
Donors with positive blood culture: could they transmit infections to the recipients?
González-Segura C., Pascual M., García Huete L., Cañizares R., Torras J., Corral L., Santos P., Ramos R., Pujol M., 2005. Transplantation Proceedings, 37 (9) pp. 3664-3666.
 
L'insuffisance rénale: évolution et prise en charge (chapter). In: Insuffisance cardiaque: traitement médical et transplantation. C. Seydoux, ed.
Seydoux C, Pascual M, 2005. pp. 193-196 dans Insuffisance cardiaque: traitement médical et transplantation, Seydoux C..
 
Le rejet: mécanisme et traitement (chapter). In: Insuffisance cardiaque: traitement médical et transplantation. C. Seydoux, ed.
Seydoux C, Goy JJ, Pascual M, 2005. Médecine et Hygiène pp. pp. 161-168.
 
Le traitement immunosuppresseur
Seydoux C, Mueller X, Pascual M, Venetz JP, 2005. pp. 127-147 dans Insuffisance cardiaque: traitement médical et transplantation., Seydoux C.
 
Multipotent progenitor cells isolated from adult human pancreatic tissue.
Todorov I., Nair I., Ferreri K., Rawson J., Kuroda A., Pascual M., Omori K., Valiente L., Orr C., Al-Abdullah I. et al., 2005. Transplantation Proceedings, 37 (8) pp. 3420-3421.
 
Options chirurgicates pour l'insuffisance cardiaque terminale [Surgical options for terminal heart failure]
von Segesser L.K., Fischer A., Vassalli G., Jeanrenaud X., Gersbach P., Seydoux C., Hurni M., Eeckhout E., Ruchat P., Kappenberger L. et al., 2005. Revue médicale suisse, 1 (21) pp. 1432-7.
 
Rejet humoral dans les allogreffes d'organes
Moll S, Venetz JP, Pascual M, 2005. pp. 239-249 dans Actualités Néphrologiques 2005, Lesavre P Drüecke T Legendre C Niaudet P Grünfeld JP.
 
Sirolimus-induced acneiform eruption.
Kunzle N., Venetz J.P., Pascual M., Panizzon R.G., Laffitte E., 2005. Dermatology, 211 (4) pp. 366-369.
 
The experience of transplantation for patients and their significant ones: A difficult encounter of two worlds
Piot-Ziegler C., Ruffiner-Boner N., Fasseur F., Demierre M., Castelao E., Ben Sassi M.L., Pascual M., 2005. p. 217 dans 19th Annual Conference of the European Health Psychology Society (EHPS), Psychology and Health.
 
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.
Fellay J., Venetz J.P., Aubert J.D., Seydoux C., Pascual M., Meylan P.R., 2005. Transplantation Proceedings, 37 (2) pp. 949-951. Peer-reviewed.
 
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.
Fellay J., Venetz J.P., Pascual M., Aubert J.D., Seudoux C., Meylan P.R., 2005. American Journal of Transplantation, 5 (7) pp. 1781-2; author reply 1783.
 
Urological complications in renal transplantation from cadaveric donor grafts: a retrospective analysis of 20 years.
Praz V., Leisinger H.J., Pascual M., Jichlinski P., 2005. Urologia internationalis, 75 (2) pp. 144-9. Peer-reviewed.
 
Hepatitis C, acute humoral rejection, and renal allograft survival
Forman J. P., Tolkoff-Rubin N., Pascual M., Lin J., 2004/12. Journal of the American Society of Nephrology, 15 (12) pp. 3249-55. Peer-reviewed.
 
Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation
Forman J. P., Lin J., Pascual M., Denton M. D., Tolkoff-Rubin N., 2004/11. American Journal of Transplantation, 4 (11) pp. 1786-91. Peer-reviewed.
 
Interferon-alpha therapy in liver transplant recipients: lack of association with increased production of anti-HLA antibodies
Cardarelli F., Pascual M., Chung R. T., Tolkoff-Rubin N., Wong W., Cosimi A. B., Saidman S. L., 2004/08. American Journal of Transplantation, 4 (8) pp. 1352-6. Peer-reviewed.
 
Update in renal transplantation.
Magee C.C., Pascual M., 2004/07. Archives of Internal Medicine, 164 (13) pp. 1373-1388.
 
Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients
Baid-Agrawal S., Delmonico F. L., Tolkoff-Rubin N. E., Farrell M., Williams W. W., Shih V., Auchincloss H., Cosimi A. B., Pascual M., 2004/04. Transplantation, 77 (8) pp. 1199-202. Peer-reviewed.
 
Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C
Ross A. S., Bhan A. K., Pascual M., Thiim M., Benedict Cosimi A., Chung R. T., 2004/04. Clinical Transplantation, 18 (2) pp. 166-73. Peer-reviewed.
 
Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation
Delgado-Borrego A., Casson D., Schoenfeld D., Somsouk M., Terella A., Jordan S. H., Bhan A., Baid S., Cosimi A. B., Pascual M. et al., 2004/03. Transplantation, 77 (5) pp. 703-10. Peer-reviewed.
 
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.
Wong W., Tolkoff-Rubin N., Delmonico F.L., Cardarelli F., Saidman S.L., Farrell M.L., Shih V., Winkelmayer W.C., Cosimi A.B., Pascual M., 2004. Clinical Transplantation, 18 (4) pp. 341-348.
 
Bilan préopératoire pour la chirurgie cardio-vasculaire en urgence [Preoperative assessment in emergency cardiovascular surgery].
von Segesser L.K., Chassot P.G., Corno A., Bernath M., Tozzi P., Marty B., Ruchat P., Gersbach P., Pascual M., Fischer A. et al., 2004. Revue Médicale de la Suisse Romande, 124 (7) pp. 395-399.
 
A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients
Goggins W. C., Pascual M. A., Powelson J. A., Magee C., Tolkoff-Rubin N., Farrell M. L., Ko D. S., Williams W. W., Chandraker A., Delmonico F. L. et al., 2003/09. Transplantation, 76 (5) pp. 798-802. Peer-reviewed.
 
The growing problem of chronic renal failure after transplantation of a nonrenal organ
Magee C., Pascual M., 2003/09. New England Journal of Medicine, 349 (10) pp. 994-6. Peer-reviewed.
 
A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation
Pascual M., Curtis J., Delmonico F. L., Farrell M. L., Williams, W. W., Jr. , Kalil R., Jones P., Cosimi A. B., Tolkoff-Rubin N., 2003/05. Transplantation, 75 (9) pp. 1501-5. Peer-reviewed.
 
Posttransplant hemolytic uremic syndrome
Magee C. C., Denton M. D., Pascual M., 2003/05. Kidney International, 63 (5) pp. 1958-9. Peer-reviewed.
 
The problem of late allograft loss in kidney transplantation.
Cardarelli F., Saidman S., Theruvath T., Tolkoff-Rubin N., Cosimi A.B., Pascual M., 2003/03. Minerva Urologica e Nefrologica, 55 (1) pp. 1-11.
 
Complement inhibition in renal diseases
Inal J. M., Pascual M., Lesavre P., Schifferli J. A., 2003/02. Nephrology Dialysis Transplantation, 18 (2) pp. 237-40. Peer-reviewed.
 
Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy.
Baid S., Tolkoff-Rubin N., Saidman S., Chung R., Williams W.W., Auchincloss H., Colvin R.B., Delmonico F.L., Cosimi A.B., Pascual M., 2003/01. American Journal of Transplantation, 3 (1) pp. 74-78.
 
Recurrent allograft HCV presenting as acute cellular rejection: successful management with interferon and ribavirin alone.
Leung J.Y., Abraczinskas D.R., Bhan A.K., Terella A.M., Pascual M., Cosimi A.B., Chung R.T., 2003. Clinical Transplantation, 17 (3) pp. 275-283.
 
Reproductive and contraceptive characteristics of premenopausal kidney transplant recipients.
Mattix Kramer H.J., Tolkoff-Rubin N.E., Williams W.W., Cosimi A.B., Pascual M.A., 2003. Progress In Transplantation, 13 (3) pp. 193-196.
 
Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection.
Watschinger B., Pascual M., 2002/09. Journal of the American Society of Nephrology, 13 (9) pp. 2420-2423.
 
Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis
Denton M. D., Magee C. C., Ovuworie C., Mauiyyedi S., Pascual M., Colvin R. B., Cosimi A. B., Tolkoff-Rubin N., 2002/06. Kidney International, 61 (6) pp. 2201-9. Peer-reviewed.
 
Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification
Mauiyyedi S., Crespo M., Collins A. B., Schneeberger E. E., Pascual M. A., Saidman S. L., Tolkoff-Rubin N. E., Williams W. W., Delmonico F. L., Cosimi A. B. et al., 2002/03. Journal of the American Society of Nephrology, 13 (3) pp. 779-87. Peer-reviewed.
 
Strategies to improve long-term outcomes after renal transplantation
Pascual M., Theruvath T., Kawai T., Tolkoff-Rubin N., Cosimi A. B., 2002/02. New England Journal of Medicine, 346 (8) pp. 580-90. Peer-reviewed.
 
Rapamycin increases transforming growth factor-beta mRNA expression in immortalized rat proximal renal tubular cells.
Swinford R.D., Pascual M., Diamant D., Tang S.S., Ingelfinger J.R., 2002/01. Transplantation, 73 (2) pp. 319-320.
 
Remission of hepatitis C virus-associated cryoglobulinemic glomerulonephritis with interferon alfa-2b and ribavirin combination therapy after liver transplantation.
Sikaneta T., Williams W.W., Chung R.T., Cosimi A.B., Pascual A.M., 2002. Transplantation, 74 (12) pp. 1767-1768.
 
Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection.
Baid S., Tolkoff-Rubin N., Farrell M.L., Delmonico F., Williams W.W., Hayden D., Ko D., Cosimi A.B., Pascual M., 2002. Transplantation Proceedings, 34 (5) pp. 1771-1773.
 
The kidney transplant program at the Massachusetts General Hospital (chapter). In: Clinical Transplants 2001. Cecka JM and Terasaki PI, eds.
Pascual M, Tolkoff-Rubin N, Farrell ML, Williams W, Auchincloss H, Ko D, Saidman S, Colvin RB, Cosimi AB, Delmonico F, 2002. pp. 123-130 dans Clinical Transplants 2001, Cecka JM Terasaki PI.
 
Managing the highly sensitized transplant recipient and B cell tolerance
Baid S., Saidman S. L., Tolkoff-Rubin N., Williams W. W., Delmonico F. L., Cosimi A. B., Pascual M., 2001/10. Current Opinion in Immunology, 13 (5) pp. 577-81. Peer-reviewed.
 
Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients
Ovuworie C. A., Fox E. R., Chow C. M., Pascual M., Shih V. E., Picard M. H., Tolkoff-Rubin N. E., 2001/10. Transplantation, 72 (8) pp. 1385-8. Peer-reviewed.
 
Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality
Baid S., Cosimi A. B., Farrell M. L., Schoenfeld D. A., Feng S., Chung R. T., Tolkoff-Rubin N., Pascual M., 2001/09. Transplantation, 72 (6) pp. 1066-72. Peer-reviewed.
 
Progress in understanding humoral rejection in kidney transplantation: implications for patient management
Pascual M. A., Crespo M., Tolkoff-Rubin N., 2001/08. Nefrologia, 21 (4) pp. 327-31. Peer-reviewed.
 
Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection
Theruvath T. P., Saidman S. L., Mauiyyedi S., Delmonico F. L., Williams W. W., Tolkoff-Rubin N., Collins A. B., Colvin R. B., Cosimi A. B., Pascual M., 2001/07. Transplantation, 72 (1) pp. 77-83. Peer-reviewed.
 
Complement activation products in plasma after heart transplantation in humans
Vallhonrat H., Williams W. W., Dec G. W., Keck S., Schoenfeld D., Cosimi A. B., Pascual M., 2001/05. Transplantation, 71 (9) pp. 1308-11. Peer-reviewed.
 
Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics
Crespo M., Pascual M., Tolkoff-Rubin N., Mauiyyedi S., Collins A. B., Fitzpatrick D., Farrell M. L., Williams W. W., Delmonico F. L., Cosimi A. B. et al., 2001/03. Transplantation, 71 (5) pp. 652-8. Peer-reviewed.
 
Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries
Mauiyyedi S., Pelle P. D., Saidman S., Collins A. B., Pascual M., Tolkoff-Rubin N. E., Williams W. W., Cosimi A. A., Schneeberger E. E., Colvin R. B., 2001/03. Journal of the American Society of Nephrology, 12 (3) pp. 574-82. Peer-reviewed.
 
Renal disease associated with hepatitis C infection after kidney and liver transplantation
Baid S., Cosimi A. B., Tolkoff-Rubin N., Colvin R. B., Williams W. W., Pascual M., 2000/07. Transplantation, 70 (2) pp. 255-61. Peer-reviewed.
 
Chronic renal allograft dysfunction: a role for mycophenolate mofetil?
Pascual M., Williams W. W., Cosimi A. B., Delmonico F. L., Farrell M. L., Tolkoff-Rubin N., 2000/04. Transplantation, 69 (8) pp. 1749-50. Peer-reviewed.
 
Prevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantation
Abrahamian G. A., Cosimi A. B., Farrell M. L., Schoenfeld D. A., Chung R. T., Pascual M., 2000/03. Liver Transplantation, 6 (2) pp. 185-90. Peer-reviewed.
 
Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries
Collins A. B., Schneeberger E. E., Pascual M. A., Saidman S. L., Williams W. W., Tolkoff-Rubin N., Cosimi A. B., Colvin R. B., 1999/10. Journal of the American Society of Nephrology, 10 (10) pp. 2208-14. Peer-reviewed.
 
Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?
De Vriese A. S., Vanholder R. C., Pascual M., Lameire N. H., Colardyn F. A., 1999/09. Intensive Care Medicine, 25 (9) pp. 903-10. Peer-reviewed.
 
Viruses and thrombotic microangiopathy
Baid S., Pascual M., Cosimi A. B., Chung R. T., Colvin R. B., Tolkoff-Rubin N., 1999/09. Transplantation, 68 (5) pp. 710-1. Peer-reviewed.
 
The clinical usefulness of the renal allograft biopsy in the cyclosporine era: a prospective study
Pascual M., Vallhonrat H., Cosimi A. B., Tolkoff-Rubin N., Colvin R. B., Delmonico F. L., Ko D. S., Schoenfeld D. A., Williams, W. W., Jr. , 1999/03. Transplantation, 67 (5) pp. 737-41. Peer-reviewed.
 
Rapid activation of the alternative pathway of complement by extracorporeal membrane oxygenation
Vallhonrat H., Swinford R. D., Ingelfinger J. R., Williams W. W., Ryan D. P., Tolkoff-Rubin N., Cosimi A. B., Pascual M., 1999/02. ASAIO Journal, 45 (1) pp. 113-4. Peer-reviewed.
 
Evolving trends in liver transplantation: an outcome and charge analysis
Gilbert J. R., Pascual M., Schoenfeld D. A., Rubin R. H., Delmonico F. L., Cosimi A. B., 1999/01. Transplantation, 67 (2) pp. 246-53. Peer-reviewed.
 
In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients
Vallhonrat H., Williams W. W., Cosimi A. B., Tolkoff-Rubin N., Ginns L. C., Wain J. C., Preffer F., Olszak I., Wee S., Delmonico F. L. et al., 1999/01. Transplantation, 67 (2) pp. 253-8. Peer-reviewed.
 
Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients
Baid S., Pascual M., Williams, W. W., Jr. , Tolkoff-Rubin N., Johnson S. M., Collins B., Chung R. T., Delmonico F. L., Cosimi A. B., Colvin R. B., 1999/01. Journal of the American Society of Nephrology, 10 (1) pp. 146-53. Peer-reviewed.
 
Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation
Pascual M., Saidman S., Tolkoff-Rubin N., Williams W. W., Mauiyyedi S., Duan J. M., Farrell M. L., Colvin R. B., Cosimi A. B., Delmonico F. L., 1998/12. Transplantation, 66 (11) pp. 1460-4. Peer-reviewed.
 
Chronic rejection and chronic cyclosporin toxicity in renal allografts
Pascual M., Swinford R. D., Ingelfinger J. R., Williams W. W., Cosimi A. B., Tolkoff-Rubin N., 1998/11. Immunology Today, 19 (11) pp. 514-9. Peer-reviewed.
 
Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy
Toth C. M., Pascual M., Chung R. T., Graeme-Cook F., Dienstag J. L., Bhan A. K., Cosimi A. B., 1998/11. Transplantation, 66 (9) pp. 1254-8. Peer-reviewed.
 
The prognostic significance of specific arterial lesions in acute renal allograft rejection
Nickeleit V., Vamvakas E. C., Pascual M., Poletti B. J., Colvin R. B., 1998/07. Journal of the American Society of Nephrology, 9 (7) pp. 1301-8. Peer-reviewed.
 
De novo collapsing glomerulopathy in renal allografts
Meehan S. M., Pascual M., Williams W. W., Tolkoff-Rubin N., Delmonico F. L., Cosimi A. B., Colvin R. B., 1998/05. Transplantation, 65 (9) pp. 1192-7. Peer-reviewed.
 
Recurrent collapsing glomerulopathy
Toth C. M., Pascual M., Williams, W. W., Jr. , Delmonico F. L., Cosimi A. B., Colvin R. B., Tolkoff-Rubin N., 1998/04. Transplantation, 65 (7) pp. 1009-10. Peer-reviewed.
 
Chronic renal failure (updated chapter). In: Scientific American Med. Rubenstein E, Federman D, eds
Tolkoff-Rubin N, Pascual M, 1998. pp. 1-15 dans Scientific American Med. chap. 10, Rubenstein E, Federman D, eds.
 
Contribution of native kidney function to total glomerular filtration rate after combined kidney-pancreas transplantation
Pascual M., Rabito C. A., Tolkoff-Rubin N., Auchincloss, H., Jr. , Farrell M. L., Delmonico F. L., Cosimi A. B., 1998/01. Transplantation, 65 (1) pp. 99-103. Peer-reviewed.
 
Anticardiolipin antibodies and hepatic artery thrombosis after liver transplantation
Pascual M., Thadhani R., Laposata M., Williams W. W., Farrell M. L., Johnson S. M., Tolkoff-Rubin N., Cosimi A. B., 1997/11. Transplantation, 64 (9) pp. 1361-4. Peer-reviewed.
 
Dialysis membrane adsorption during CRRT
Swinford R. D., Baid S., Pascual M., 1997/11. American Journal of Kidney Diseases, 30 (5 Suppl 4) pp. S32-7. Peer-reviewed.
 
Nephrotic syndrome after liver transplantation in a patient with hepatitis C virus-associated glomerulonephritis
Pascual M., Thadhani R., Chung R. T., Williams, W. W., Jr. , Meehan S., Tolkoff-Rubin N., Colvin R., Cosimi A. B., 1997/10. Transplantation, 64 (7) pp. 1073-6. Peer-reviewed.
 
Cytotoxicity and apoptosis in human renal allografts: identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP-17 (TIA-1) and cells with fragmented nuclear DNA
Meehan S. M., McCluskey R. T., Pascual M., Preffer F. I., Anderson P., Schlossman S. F., Colvin R. B., 1997/05. Lab Invest, 76 (5) pp. 639-49. Peer-reviewed.
 
Biological effects and fate of a soluble, dimeric, 80-kDa tumor necrosis factor receptor in renal transplant recipients who receive OKT3 therapy
Wee S., Pascual M., Eason J. D., Schoenfeld D. A., Phelan J., Boskovic S., Blosch C., Mohler K., Cosimi A. B., 1997/02. Transplantation, 63 (4) pp. 570-7. Peer-reviewed.
 
Acute renal failure: role of dialysis membrane biocompatibility
Pascual M., Swinford R. D., Tolkoff-Rubin N., 1997. Annual Review of Medicine, 48 pp. 467-76. Peer-reviewed.
 
Paraproteins and complement depletion: pathogenesis and clinical syndromes
Pascual M., Mach-Pascual S., Schifferli J. A., 1997/01. Seminars in Hematology, 34 (1 Suppl 1) pp. 40-8. Peer-reviewed.
 
Minimizing the toxicity of antilymphocyte antibody therapy
Pascual M., Rubin R. H., Cosimi A. B., 1996/08. Transplantation Proceedings, 28 (4) pp. 2113-4. Peer-reviewed.
 
Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family
Topaloglu R., Bakkaloglu A., Slingsby J. H., Mihatsch M. J., Pascual M., Norsworthy P., Morley B. J., Saatci U., Schifferli J. A., Walport M. J., 1996/08. Kidney International, 50 (2) pp. 635-42. Peer-reviewed.
 
Proteolytic cleavage of leukocyte membrane proteins: lessons from CRI
Sadallah S., Schifferli J. A., Pascual M., 1996/07. Immunology Today, 17 (7) p. 345. Peer-reviewed.
 
Acute renal failure
Thadhani R., Pascual M., Bonventre J. V., 1996/05. New England Journal of Medicine, 334 (22) pp. 1448-60. Peer-reviewed.
 
New synthetic sulfated oligosaccharides prolong survival of cardiac xenografts by inhibiting release of heparan sulfate from endothelial cells
Deng S., Pascual M., Lou J., Buhler L., Wessel H. P., Grau G., Schifferli J. A., Morel P., 1996/05. Transplantation, 61 (9) pp. 1300-5. Peer-reviewed.
 
Is adsorption an important characteristic of dialysis membranes?
Pascual M., Tolkoff-Rubin N., Schifferli J. A., 1996/02. Kidney International, 49 (2) pp. 309-13. Peer-reviewed.
 
Chronic renal failure
Tolkof-Rubin N, Pascual M, 1996. pp. 1-15 dans Scientific American Med. chap. 10, Rubenstein E; Federman D.
 
Chronic renal failure (Chapter)
pascual m, 1996. pp. 1-15, Sect. 10 dans Scientific american med, Rubenstein E Federman D.
 
Complement depletion during haemofiltration with polyacrilonitrile membranes
Gasche Y., Pascual M., Suter P. M., Favre H., Chevrolet J. C., Schifferli J. A., 1996/01. Nephrology Dialysis Transplantation, 11 (1) pp. 117-9. Peer-reviewed.
 
Evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of OKT3-associated acute clinical syndrome
Eason J. D., Pascual M., Wee S., Farrell M., Phelan J., Boskovic S., Blosch C., Mohler K. M., Cosimi A. B., 1996/01. Transplantation, 61 (2) pp. 224-8. Peer-reviewed.
 
Hepatitis C and glomerulonephritis (Chapter). In: International Yearbook of Nephrology. Andreucci VE, Fine L, eds
Pascual M, Schifferli JA, 1996. pp. 20-26 dans International Yearbook of Nephrology. Andreucci VE, Fine L, ed, Andreucci VE Fine L.
 
Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease
Thadhani R., Pascual M., Nickeleit V., Tolkoff-Rubin N., Colvin R., 1996/01. Lancet, 347 (8996) pp. 231-3. Peer-reviewed.
 
Another function of erythrocytes: transport of circulating immune complexes
Pascual M., Schifferli J. A., 1995/10. InfusionsThérapie und Transfusionsmedizin, 22 (5) pp. 310-5. Peer-reviewed.
 
Delayed renal allograft function. Importance of the dialysis membrane
Pascual M., Tolkoff-Rubin N., 1995/10. Transplantation, 60 (7) p. 769. Peer-reviewed.
 
Partial C4 deficiency in two children with systemic lupus erythematosus
Bakkaloglu A., Pascual M., Schifferli J. A., Ozen S., Besbas N., Saatci U., 1995/06. Turkish Journal of Pediatrics, 37 (2) pp. 147-51. Peer-reviewed.
 
Complement in human diseases: looking towards the 21st century
Pascual M., French L. E., 1995/02. Immunology Today, 16 (2) pp. 58-61. Peer-reviewed.
 
Complement activation by LDL-apheresis using dextran sulphate
Pascual M., Blanc E., Schifferli J. A., 1995. Nephrology Dialysis Transplantation, 10 (8) pp. 1475-6. Peer-reviewed.
 
Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage
Danielsson C., Pascual M., French L., Steiger G., Schifferli J. A., 1994/11. European Journal of Immunology, 24 (11) pp. 2725-31. Peer-reviewed.
 
Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes
Pascual M., Steiger G., Sadallah S., Paccaud J. P., Carpentier J. L., James R., Schifferli J. A., 1994/03. Journal of Experimental Medicine, 179 (3) pp. 889-99. Peer-reviewed.
 
Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS
Pascual M., Danielsson C., Steiger G., Schifferli J. A., 1994/03. European Journal of Immunology, 24 (3) pp. 702-8. Peer-reviewed.
 
Release of vesicles enriched in complement receptor 1 from human erythrocytes
Pascual M., Lutz H. U., Steiger G., Stammler P., Schifferli J. A., 1993/07. Journal of Immunology, 151 (1) pp. 397-404. Peer-reviewed.
 
Specific interactions of polystyrene biomaterials with factor D of human complement
Pascual M., Plastre O., Montdargent B., Labarre D., Schifferli J. A., 1993/07. Biomaterials, 14 (9) pp. 665-70. Peer-reviewed.
 
Inhibition of complement alternative pathway in mice with Fab antibody to recombinant adipsin/factor D
Pascual M., Catana E., White T., Spiegelman B. M., Schifferli J. A., 1993/06. European Journal of Immunology, 23 (6) pp. 1389-92. Peer-reviewed.
 
Adsorption of complement factor D by polyacrylonitrile dialysis membranes
Pascual M., Schifferli J. A., 1993/04. Kidney International, 43 (4) pp. 903-11. Peer-reviewed.
 
Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes.
Pascual M., Duchosal M.A., Steiger G., Giostra E., Pechère A., Paccaud J.P., Danielsson C., Schifferli J.A., 1993. Journal of Immunology, 151 (3) pp. 1702-1711. Peer-reviewed.
 
Le recepteur CR1 erythrocytaire: liaison et transport des complexes immuns dans la circulation sanguine. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation]
Pascual M., Schifferli J. A., 1993/01. Schweizerische Medizinische Wochenschrift, 123 (3) pp. 39-43. Peer-reviewed.
Removal of complement factor D by adsorption on polymethylmethacrylate dialysis membranes
Pascual M., Schifferli J. A., Pannatier J. G., Wauters J. P., 1993. Nephrology Dialysis Transplantation, 8 (11) pp. 1305-6. Peer-reviewed.
 
Serum TNF in patients with severe malaria treated by exchange transfusion
Loutan L., Plancherel C., Soulier-Lauper M., Pascual M., Subilia L., Chevrolet J. C., Unger P. F., Grau G. E., 1992/12. Tropical Medicine and Parasitology, 43 (4) pp. 285-6.
 
The binding of immune complexes by the erythrocyte complement receptor 1 (CR1)
Pascual M., Schifferli J. A., 1992/10. Immunopharmacology, 24 (2) pp. 101-6. Peer-reviewed.
 
Nouveautes sur le systeme du complement en nephrologie. [New findings on the complement system in nephrology]
Pascual M., French L., 1992. Nephrologie, 13 (2) p. 99. Peer-reviewed.
 
L'insuffisance rénale et le complément
Pascual M., Schifferli J.A., 1991. Médecine et Hygiène, 49 (1876) pp. 504-513.
 
Le facteur D du complément: toxine urémique [Factor D of complement: Uremic toxin?].
Pascual M., 1991. Néphrologie, 12 (5) pp. 215-219. Peer-reviewed.
 
Stroke secondary to multiple spontaneous cholesterol emboli
Pascual M., Baumgartner J. M., Bounameaux H., 1991. Vasa, 20 (1) pp. 74-7. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University